News for Aethlon Medical, Inc. (AEMD)

SAN DIEGO - May 15, 2025 (Investorideas.com Newswire) Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to trea...

Aethlon Medical (AEMD) has announced a significant development with the publication of a pre-clinical ex vivo study on bioRxiv. This study, titled ”œEx Vivo Re

MIAMI, March 25, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com, a leading independent small cap media portal, announces the schedule of the 80th Emerging Growth

SAN DIEGO - March 10, 2025 (Investorideas.com Newswire) Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to tr...

PR NewswireSAN DIEGO, March 10, 2025 Preclinical Data Suggests Expanded Therapeutic Potential of the Hemopurifier® Beyond Virology and Oncology Results Su

SAN DIEGO - January 29, 2025 (Investorideas.com Newswire) Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to ...

**media[544182]**

MIAMI, Feb. 19, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 79th Emerging Growth Co

MIAMI, Feb. 18, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 79th Emerging Growth Co

Significant Transaction by Ikarian Capital, LLC (Trades, Portfolio) On December 31, 2024, Ikarian Capital, LLC (Trades, Portfolio) executed a noteworthy transac

SAN DIEGO - February 13, 2025 (Investorideas.com Newswire) Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to...

Feb 12, 2025 / 09:30PM GMTOperator Good day, and welcome to the Aethlon Medical third quarter fiscal 2025 earnings and corporate update call. (Operator Instruct

Earnings Call Insights: Aethlon Medical (NASDAQ:AEMD) Q3 2025 Management ViewCEO Jim Frakes noted that Aethlon Medical has made significant progress in...

Aethlon Medical, Inc. (NASDAQ:AEMD) Q3 2025 Earnings Conference Call February 12, 2025 4:30 PM ETCompany ParticipantsJim Frakes – Chief Executive...

PR NewswireSAN DIEGO, Feb. 12, 2025 Key Milestone Achieved: First Patient treated in Hemopurifier® Safety, Feasibility, and Dose Finding Study for Solid T

SAN DIEGO - February 12, 2025 (Investorideas.com Newswire) Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to...

Aethlon Medical (AEMD) unveils Q3 earnings on Feb 12 after market close.

SAN DIEGO - February 5, 2025 (Investorideas.com Newswire) Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to ...

January 29, 2025 (Investorideas.com Newswire) Investorideas.com (www.investorideas.com), a go-to platform for big investing ideas for stock traders, including b...